Acrivon Therapeutics, Inc. Common Stock (ACRV) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 383K | -911K | 0 | 300K | 311K | 303K | 0 | 0 | 224K | 149K | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -383K | 911K | 0 | -300K | -311K | -303K | 0 | 0 | -224K | -149K | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | -23.15% | 400.66% | - | - | -38.84% | -103.36% | - | - | - | - | - | - |
| Operating Expenses | 19.52M | 21.03M | 19.69M | 22.35M | 21.35M | 24.65M | 25.14M | 21.44M | 17.44M | 20.9M | 16.14M | 15.52M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 4.74M | 5.37M | 6.04M | 6.47M | 6.25M | 6.32M | 6.28M | 6.41M | 6.2M | 5.58M | 5.87M | 5M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 14.78M | 15.05M | 13.65M | 16.18M | 15.41M | 18.33M | 18.86M | 15.03M | 11.25M | 15.33M | 10.27M | 10.52M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 611K | 0 | -300K | -311K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -19.9M | -20.12M | -19.69M | -22.65M | -21.66M | -24.95M | -25.14M | -21.44M | -17.67M | -21.05M | -16.14M | -15.52M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 8.12% | 19.39% | 21.69% | -5.65% | -22.61% | -18.53% | -55.79% | -38.13% | -22.75% | -111.69% | -68.53% | -161.94% |
| EBITDA | -19.52M | -21.03M | -19.34M | -22.35M | -21.35M | -24.65M | -24.89M | -21.21M | -17.44M | -20.9M | -16M | -15.39M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 8.58% | 14.7% | 22.3% | -5.38% | -22.4% | -17.92% | -55.52% | -37.8% | -22.26% | -112.87% | -69.19% | -163.23% |
| D&A (Non-Cash Add-back) | 383K | -911K | 349K | 300K | 311K | 303K | 251K | 228K | 224K | 149K | 133K | 129K |
| EBIT | -19.9M | -25.19M | -19.69M | -21.01M | -19.68M | -22.83M | -25.14M | -21.44M | -17.67M | -19.25M | -16.14M | -15.52M |
| Net Interest Income | 989K | 1.25M | 1.51M | 1.73M | 2M | 2.36M | 2.7M | 2.69M | 1.45M | -1.64M | 1.77M | 1.77M |
| Interest Income | 989K | 1.25M | 1.51M | 1.73M | 2M | 2.36M | 2.7M | 2.69M | 1.45M | 0 | 1.77M | 1.77M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.64M | 0 | 0 |
| Other Income/Expense | 860K | 1.13M | 1.45M | 1.64M | 1.98M | 2.12M | 2.7M | 2.64M | 1.18M | 1.8M | 1.67M | 1.61M |
| Pretax Income | -19.04M | -18.98M | -18.23M | -21.01M | -19.68M | -22.83M | -22.44M | -18.8M | -16.49M | -19.25M | -14.47M | -13.91M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -19.04M | -18.98M | -18.23M | -21.01M | -19.68M | -22.83M | -22.44M | -18.8M | -16.49M | -19.25M | -14.47M | -13.91M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 3.24% | 16.85% | 18.75% | -11.75% | -19.37% | -18.59% | -55.13% | -35.1% | -29.24% | -115.61% | -57.27% | -139.07% |
| Net Income (Continuing) | -19.04M | -18.98M | -18.23M | -21.01M | -19.68M | -22.83M | -22.44M | -18.8M | -16.49M | -19.25M | -14.47M | -13.91M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.49 | -0.49 | -0.47 | -0.55 | -0.51 | -0.60 | -0.59 | -0.52 | -0.73 | -0.86 | -0.66 | -0.63 |
| EPS Growth % | 3.92% | 18.33% | 20.34% | -5.77% | 30.14% | 30.23% | 10.61% | 17.46% | -43.14% | -126.32% | -40.43% | -43.18% |
| EPS (Basic) | -0.49 | -0.49 | -0.47 | -0.55 | -0.51 | -0.60 | -0.59 | -0.52 | -0.73 | -0.86 | -0.66 | -0.63 |
| Diluted Shares Outstanding | 38.72M | 38.51M | 38.56M | 38.46M | 38.35M | 38.24M | 38.11M | 36.13M | 22.59M | 22.34M | 22.08M | 21.97M |
| Basic Shares Outstanding | 38.72M | 38.51M | 38.56M | 38.46M | 38.35M | 38.24M | 38.11M | 36.13M | 22.59M | 22.34M | 22.08M | 21.97M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |